He is a Scientist at the Robarts Research Institute and an Investigator with the Ontario Institute for Cancer Research, where he is the Co-Director of the Translational Imaging Research Facility 3.0-Tesla MRI. His research program is focused on development of novel cellular, molecular and metabolic MRI assays and their application to cancer diagnosis, tumour characterization, stratification of treatment and treatment response.